Objective: We examined whether supplementation with vitamin A and/or vitamins B, C, and E to HIV-infected women during pregnancy and lactation is related to increased concentrations of vitamins A, B12, and E in their infants during the first 6 months of life. Design: We carried out a randomized clinical trial among 716 mother-infant pairs in Dar-es-Salaam, Tanzania. Women were randomly allocated to receive a daily oral dose of one of four regimens: vitamin A, multivitamins (B, C, and E), multivitamins including A, or placebo. Supplementation started at first prenatal visit and continued after delivery throughout the breastfeeding period. The serum concentration of vitamins A, E and B12 was measured in infants at 6 weeks and 6 months postpartum. Results: Maternal vitamin A supplementation increased serum retinol in the infants at 6 weeks (mean difference ¼ 0.09 mmol/l, Po0.0001) and 6 months (mean difference ¼ 0.06 mmol/l, P ¼ 0.0002), and decreased the prevalence of vitamin A deficiency, but had no impact on serum vitamins E or B12. Multivitamins increased serum vitamin B12 at 6 weeks and 6 months (mean differences ¼ 176 pmol/l, Po0.0001 and 127 pmol/l, Po0.0001, respectively) and vitamin E (mean differences ¼ 1.8 mmol/l, P ¼ 0.0008 and 1.1 mmol/l, P ¼ 0.004, respectively) and decreased the prevalence of vitamin B12 deficiency. Conclusions: Vitamin supplementation to HIV-1-infected women is effective in improving the vitamin status of infants during the first 6 months of age.
Introduction
Micronutrient deficiencies during infancy constitute a serious public health problem worldwide and have a devastating impact on survival, growth, neurological development, and morbidity from infectious diseases (Humphrey et al, 1996; von Schenck et al, 1997; van Dusseldorp et al, 1999; Neumann et al, 2002) . Infants born to HIV-infected women, especially those in developing countries, may be particularly vulnerable to micronutrient deficiencies (Periquet et al, 1995; Omene et al, 1996) .
The vitamin status of neonates strongly relies on that of their mothers before and after delivery (Baker et al, 1981; Stoltzfus et al, 1993; Bjorke Monsen et al, 2001) . Studies among presumably HIV-uninfected women have shown that supplementation with vitamins A and B12 during early lactation increases the concentrations of nutrients in breast milk and results in improved vitamin status of infants during the first 6 months (Thomas et al, 1979; Sneed et al, 1981; Stoltzfus et al, 1993; Roy et al, 1997; Muslimatun et al, 2001; Bahl et al, 2002) . Therefore, it has been proposed that vitamin supplementation to lactating mothers may be an efficient way to improve the vitamin status of both mothers and infants (Stoltzfus et al, 1993) . However, it is unknown whether this strategy is also useful among HIV-infected women, who may be at higher risk than HIV-uninfected mothers to develop profound micronutrient deficiencies (Friis et al, 2001) . We have shown that multivitamin supplementation to mothers during lactation decreases the risk of diarrheal morbidity in infants (Fawzi et al, 2003) ; this effect could be mediated in part through an improvement in the child's micronutrient status.
Using data from a randomized clinical trial conducted in Tanzania, we examined whether supplementation with vitamin A and/or vitamins B, C, and E to HIV-infected women during pregnancy and lactation is related to increased concentrations of vitamins A, B12, and E in their infants during the first 6 months of life.
Methods

Study design and population
From April 1995 to July 1997, 1078 HIV-infected pregnant women attending four prenatal clinics in Dar es Salaam, Tanzania, were enrolled in a clinical trial of vitamin supplements in relation to vertical transmission and disease progression. Details of the trial design have been reported elsewhere (Fawzi et al, 1998) . Briefly, eligible women were between 12 and 27 weeks of gestational age at first visit, resided in Dar es Salaam, and intended to stay in the city until delivery and for at least 1 y thereafter. Women who consented to participate in the study were randomly assigned, in a 2 by 2 factorial design, to receive a daily oral dose of one of four regimens: (1) vitamin A alone (5000 IU of preformed vitamin A (as palmitate) plus 30 mg of beta carotene), (2) multivitamins that did not include vitamin A (20 mg of vitamin B1 (as mononitrate), 20 mg of vitamin B2, 25 mg of vitamin B6 (as hydrochloride), 100 mg of niacin (as niacinamide), 50 mg of vitamin B12, 500 mg of ascorbic acid, 30 mg of vitamin E (as DL-alpha-tocopherol acetate), and 0.8 mg of folic acid), (3) multivitamins that included vitamin A (same doses as above), or (4) placebo. The supplements were administered from enrollment throughout the pregnancy and lactation periods. At delivery, women in groups (1) and (3) received an additional oral dose of vitamin A (200 000 IU), whereas women in groups (2) and (4) were given a placebo. Active tablets and placebo were identical in size and color. Compliance with the experimental regimens, assessed using pill counts, was 490% .
At the first visit, trained research assistants collected information on sociodemographic variables and obstetric history; a study physician carried out a complete physical examination and collected blood, stool, and genital swab specimens for laboratory tests that included a complete blood cell and CD4 counts, serum concentration of nutrients, and infections by malaria, intestinal parasites, gonorrhea, and syphilis. Participants were followed during monthly visits to the study clinic and at delivery. Blood samples were collected from their children at birth and during postnatal visits at 6 weeks and 6 months. All women and infants received the standard prenatal and child care services in Tanzania, which include maternal folate and iron supplementation and malaria prophylaxis during pregnancy, as well as the administration of 100 000 IU vitamin A to infants at 6 months of age and 200 000 IU every 6 months thereafter. Antiretroviral treatment was not available at the time of the study. In accordance with the guidelines of the World Health Organization and the Tanzanian Ministry of Health, HIV infected women were provided with information about the benefits and risks associated with infant feeding options; however, the decision on whether to breast feed was ultimately made by the mother and breast feeding was almost universally adopted in this population.
Biochemical analyses
Serum samples obtained from the infants were stored at À701C and transported for analyses to the Clinical Chemistry Laboratory of Children's Hospital, Boston. Vitamins A and E were analyzed by high-performance liquid chromatography using the Shimadzu system (DeLeenheer et al, 1979) . The concentration of vitamin E was adjusted for serum cholesterol using the method of residuals (Willett, 1998) . Vitamin B12 was measured by a competitive magnetic separation assay on the Technico Immuno-1 analyzer (Bayer, Tarytown, NY, USA). Vitamin C was not measured because samples were not stabilized properly at the time of collection.
Statistical analyses
There were 984 live births. Of these, 716 were singleton and had at least one blood sample available before 6 months of age (610 at 6 weeks and 573 at 6 months). This subset, which constituted the study base for the analyses, did not differ from the rest of live births in terms of sociodemographic characteristics, disease status of the mother, other variables at baseline, or treatment assignment. Given that the follow-up visits were not always attended at the exact scheduled times, for data analyses purposes we considered 6-week samples to be those obtained between 22 and 98 days postpartum (3-14 weeks), whereas 6-month samples were those collected between 99 and 266 days (14-38 weeks). Typically, a maximum of one sample per child was available within each window; in the few instances when more than one sample existed, we selected the one closest to exactly 6 weeks or 6 months after delivery, respectively; for most infants, samples were within 14 days of the exact expected ages (6 weeks or 6 months). Means and s.d. of sampling time were 51718 days for the '6 weeks' window and 181727 days for the '6 months' window. After biochemical analysis, the number of infants with samples at each time point was: (1) vitamins A and E: 595 at 6 weeks, 560 at 6 months, and 443 at both time points; and (2) vitamin B12: 550 at 6 weeks, 496 at 6 months, and 361 at both time points.
Vitamin concentrations in infants were considered both as continuous and categorical end points. For the latter, vitamin A deficiency was defined as serum concentration of o0. 70 and o0.35 mmol/l (WHO, 1998; de Pee & Dary, 2002) , vitamin B12 deficiency as o150 pmol/l (Beck, 2001) , and vitamin E as 11.6 mmol/l (Sauberlich, 1999) . Although there is no clear cutoff for vitamin A deficiency in younger infants, we decided to use both o0.35 and o0.70 mmol/l because this is a population with extremely low levels of plasma vitamin A; 89% of the children were below 0.70 mmol/l at 6 weeks and 84% at 6 months.
Analyses were intent to treat. We assessed the effect of vitamin A by comparing regimens that included vitamin A (groups (1) and (3)) against regimens that did not include vitamin A (groups (2) and (4)); similarly, the effect of multivitamins (B, C, and E) was assessed by comparing groups (2) and (3) against groups (1) and (4). The statistical significance of differences in the mean concentration of vitamins at 6 weeks or 6 months between treatment arms was assessed using Wilcoxon's rank-sum tests, whereas treatment effects on the prevalence of vitamin deficiencies were tested with the w 2 test. In addition to the analyses at 6 weeks and 6 months separately, we conducted supplemental analyses to examine the effect of maternal supplements on the change in vitamin concentrations between 6 weeks and 6 months in the subsets of infants who had the two measurements. Differences in the slope of change by treatment arm were obtained from mixed models for repeated measures (PROC MIXED; SAS Institute, Cary, NC, USA), and 95% confidence intervals around the mean differences were constructed using robust estimators of the variance (White, 1980) . Finally, we examined whether the effect of vitamin supplements was modified by baseline characteristics using the likelihood ratio test. We repeated the analyses adjusting for variables that were not evenly distributed by treatment arm at baseline and obtained similar results; therefore, only unadjusted results are presented. Analyses were carried out with the Statistical Analyses System Software (SAS Institute). 
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Results
On average, mothers were 25 y old, attended the first prenatal visit at week 20, and had between 5 and 8 y of education. Breastfeeding was almost universal in this population with an average duration of 16 (s.d. ¼ 7) months and a prevalence of 95% at both 6 weeks and 6 months. The distribution of most maternal baseline characteristics did not differ across treatment arms, except for serum vitamin E, hemoglobin levels, and infection with intestinal parasites (Table 1) .
At 6 weeks, serum vitamin A was 0.09 mmol/l significantly higher among infants from mothers who received vitamin A compared to those from mothers who did not receive the supplement (Po0.0001) ( Table 2 ). The treatment effect at 6 months was 0.06 mmol/l (P ¼ 0.0002). Vitamin A supplementation had no impact on serum vitamin E or vitamin B12 concentrations at any time point.
Multivitamins had a statistically significant positive effect on serum concentrations of vitamins E and B12 at 6 weeks and 6 months ( Table 3) . However, at 6 weeks there was an apparent negative effect of multivitamins on retinol concentrations.
We next compared the effect of treatments on the proportion of infants with vitamin A, vitamin E, or vitamin B12 deficiencies ( Table 4 ). The prevalence of vitamin A deficiency (o0.35 mmol/l) was significantly lower among infants whose mothers were supplemented with vitamin A compared to those unsupplemented (no vitamin A arm), both at 6 weeks (P ¼ 0.0001) and at 6 months (P ¼ 0.02). The prevalence of vitamin E deficiency (o11.6 mmol/l) was significantly lower among infants whose mothers were supplemented with multivitamins compared to those unsupplemented (no multivitamins arm) at 6 months (P ¼ 0.03), and it was also significantly lower among infants whose mothers were supplemented with vitamin A (P ¼ 0.04). Similarly, the prevalence of vitamin B12 deficiency (o150 pmol/l) was significantly lower among infants born to mothers supplemented with multivitamins at 6 weeks (Po0.0001) and 6 months (Po0.0001). Multivitamins appeared to increase the prevalence of vitamin A deficiency at 6 months (P ¼ 0.02).
We examined the effect of vitamin supplements on the change in vitamin concentrations among infants with samples at both time points. Multivitamins did not appear to further increase the concentration of vitamin B12 after 6 weeks, whereas a modest increase from 6 weeks to 6 months was observed in infants born to mothers who did not receive multivitamins (P for the time Â treatment interaction ¼ 0.02) (Figure 1 ). This increase, however, was not sufficient to reach the high concentrations of infants from supplemented mothers. There were no other significant effects of either treatment arm on the change in vitamin concentrations of infants between 6 weeks and 6 months of age. Vitamin E concentrations appeared to decrease over time (À1.21 mmol/l, 95%CI: À2.04, À0.37), whereas vitamin A seemed to increase (0.03 mmol/l, 95%CI: 0.01, 0.05), independent of treatment assignment.
Maternal characteristics at baseline including CD4, serum vitamin A, serum vitamin E, parity, and hemoglobin concentration did not modify the effect of vitamin supplements on the infants' serum concentrations of vitamins A, E, and B12.
Discussion
We found that vitamin A given to HIV-infected mothers during pregnancy and lactation increases serum vitamin A in their infants during the first 6 months of life. Similarly, multivitamins (B, C, and E) increase serum vitamins B12 and E. Supplementation was also associated with significant reductions in the prevalence of vitamins A and B12 deficiency.
The observed improvements in the infants' vitamin status through maternal supplementation are likely to be mediated by an increase in the vitamin content of breast milk. Although the effect of supplementation on breast milk vitamin concentrations has not been ascertained in this population yet, in one previous trial among HIV-infected women daily supplementation with vitamin A during pregnancy was related to increased breast milk retinol Effect of vitamin supplementation to HIV-infected pregnant women A Baylin et al concentrations at 6 weeks postpartum (Semba et al, 2000) . Other trials among presumably HIV-uninfected mothers have reported increases of vitamin A in breast milk following supplementation during pregnancy (Muslimatun et al, 2001) or postpartum (Stoltzfus et al, 1993; Roy et al, 1997; Rice et al, 1999; Bahl et al, 2002) . In some of these intervention studies, the increase in breast milk retinol concentrations among supplemented mothers coincided with a reduced prevalence of vitamin A deficiency in the infants at 6 months (Stoltzfus et al, 1993; WHO, 1998; Rice et al, 1999) . Supplementation with B vitamins during lactation has also been associated with increased concentrations in breast milk (Prentice et al, 1983) . The extent to which the improvement in vitamin concentrations at 6 weeks of age is due to antenatal supplementation rather than postpartum is not known and could not be ascertained in our study. Placental transfer of retinol is tightly regulated , but antenatal Effect of vitamin supplementation to HIV-infected pregnant women A Baylin et al supplementation could increase the concentration of vitamin A in early milk (Muslimatun et al, 2001) . Therefore, both mechanisms could be possible for vitamin A, and also for vitamin B12 (Perez-D'Gregorio & Miller, 1998) . On the other hand, placental transfer of vitamin E is not efficient (Leger et al, 1998; Brigelius-Flohe et al, 2002 ) and the effect is likely attributable to postnatal supplementation. When comparing infants from multivitamin-supplemented mothers to infants from non-multivitamin-supplemented mothers, we found a major effect in serum vitamin B12 at 6 weeks that was sustained through 6 months of age. Observational studies had suggested that the vitamin B12 status of newborns is strongly associated with that of their mothers (Bjorke Monsen et al, 2001) and that correction of deficiencies through vitamin B12 supplementation among presumably HIV-uninfected mothers resulted in greater B12 concentrations in breast milk (Thomas et al, 1979 (Thomas et al, , 1980 Sneed et al, 1981) . It has been described that vitamin B12 concentrations decrease in the newborn during the first 6-8 weeks (Bjorke Monsen & Ueland, 2003) ; our results suggest that maternal supplementation with multivitamins at multiples of the recommended dietary allowance (RDA) in USA could prevent such a decrease. We have previously reported that multivitamin supplementation to this group of mothers resulted in decreased morbidity from diarrhea, higher CD4 þ cell counts (Fawzi et al, 2003) , and improved ponderal growth (Villamor et al, 2005) among children during the first 2 y of life. Supplementation-mediated improvement in the child's nutritional status as reported in the present study could provide a mechanistic explanation for the effects on child outcomes.
The observed effect of multivitamin supplementation on serum vitamin E, although statistically significant, was not as strong as that seen on vitamin B12. Serum vitamin E is not an adequate biomarker of vitamin E intake at normal intakes in adults (Kardinaal et al, 1995; El-Sohemy et al, 2001) , although it can reflect dietary intake when supplements are included (Ascherio et al, 1992) . In our study, mothers received vitamin E at doses that were two times higher than the US RDA for pregnancy, and 1.6 times for lactation; these high doses were likely to represent a significant increase in breast milk concentrations and infant intake. Direct supplementation of infants with daily vitamin E also resulted in greater vitamin E concentrations at 3 months of age in a previous trial among HIV-negative infants (Delvin et al, 2000) . We observed an apparent decrease in vitamin E over time, independent of treatment arm. The nature of this decrease is not known; it may represent an increase in antioxidant requirements in infants who have become infected with HIV. The fact that maternal supplementation did not prevent this decrease could suggest the occurrence of a progressive fall in excretion of vitamin E on breast milk. Alternatively, the concentration of long-chain polyunsaturated fatty acids (Kaempf-Rotzoll et al, 2003) and certain enzymes like milk bile salt-stimulated lipase (Ghebremeskel et al, 1999) could have affected the absorption of vitamin E by the infants. The relation between vitamin E status of children and clinical outcomes needs to be ascertained in future prospective studies.
Multivitamin supplementation was related to slightly decreased retinol concentrations at 6 weeks of age. Although this may be a chance finding, the potential for a negative interaction between vitamins E and A was suggested by a study in which high daily doses of alpha-tocopherol (800 IU) administered to well-nourished adults during 16 weeks caused small decreases in serum carotenoids and retinol concentrations (Willett et al, 1983) . Other studies showed increased serum vitamin A after vitamin E supplementation (Farrell & Bieri, 1975; Jagadeesan & Reddy, 1978) , or increased serum vitamin E after vitamin A supplementation (Goodman et al, 1994) , consistent with our findings at 6 months.
Even though maternal vitamin A supplementation was associated with improved vitamin A status in the infants, we have previously reported that women who received vitamin A during pregnancy and lactation were more likely to transmit the virus to their offspring . These findings do not encourage the daily administration of vitamin A and beta-carotene to HIV-infected women during pregnancy or lactation. The effects of a single mega dose administered during the early postpartum, as suggested from studies of HIV-uninfected women (Stoltzfus et al, 1993; Roy et al, 1997; Rice et al, 1999; Bahl et al, 2002) , are currently being assessed in a randomized clinical trial among HIV-infected women (Zijenah et al, 2004) . Direct Effect of vitamin supplementation to HIV-infected pregnant womensupplementation to neonates is one alternative that has proven effective in decreasing child mortality (Humphrey et al, 1996; Rahmathullah et al, 2003) ; however, it is not known whether vitamin A supplementation to HIV-uninfected infants born to HIV-infected mothers could increase their risk of becoming infected. Vitamin A supplementation to HIV-infected infants appears to be safe and effective to decrease mortality (Fawzi et al, 1999) , morbidity from diarrhea (Coutsoudis et al, 1995) , and growth retardation (Villamor et al, 2002) . Supplementation starting at 6 months among children who are not at risk of becoming HIV infected is an important public health intervention to decrease overall mortality and morbidity from measles, severe diarrhea, and possibly malaria (Villamor & Fawzi, 2000) . One limitation of the present study is the use of serum vitamins as biomarkers of deficiency, since serum concentrations do not always reflect accurately the underlying vitamin status (Rucker et al, 2001) . However, our main goal was to examine the overall difference in serum vitamins between infants from supplemented mothers and infants with mothers who were not supplemented, and our findings are physiologically plausible. Also, although we do not have information on complementary foods, we expect that their impact on serum vitamins would be minor when compared to the high dose of vitamins received through breastfeeding. A second limitation is that a potential protective effect of multivitamins on child survival could have resulted in a biased sample. Yet, the sample used for this study is similar in baseline characteristics to the initial study population. A third potential limitation is related to the spread in time of blood sampling. Samples were not always taken at the attempted goal, 6 weeks and 6 months. However, the time windows of the actual dates around the target were narrow, and similar results were obtained by excluding infants at the extremes of the time distribution. Finally, all children received an extra dose of vitamin A at 6 months according to the standard of pediatric care in Tanzania. Although we do not know if all of the children received their extra dose before the blood sample was taken, the overall increase of serum vitamin A over time independent of maternal supplementation suggests that at least part of them received their dose before the blood sample. Although this is a limitation for the interpretation of the analysis at 6 months, we expect that the distribution of children not receiving an extra dose of vitamin A before the blood sample would be evenly distributed between treatment arms due to randomization. The strength of our study relies on its randomized design. Imbalances in some of the baseline characteristics are unlikely to cause bias, since adjustment for those variables did not change the results.
In conclusion, this study shows that supplementation with multivitamins during pregnancy and lactation to HIVinfected women is an effective strategy to improve the vitamin status of their infants. This improvement in the infants' micronutrient status could explain in part a previously observed beneficial effect of multivitamin supplementation on child morbidity, immune status, and growth.
